Dorothea Scandella

3.8k total citations
60 papers, 3.2k citations indexed

About

Dorothea Scandella is a scholar working on Hematology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Dorothea Scandella has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 27 papers in Genetics and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Dorothea Scandella's work include Hemophilia Treatment and Research (55 papers), Platelet Disorders and Treatments (33 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (27 papers). Dorothea Scandella is often cited by papers focused on Hemophilia Treatment and Research (55 papers), Platelet Disorders and Treatments (33 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (27 papers). Dorothea Scandella collaborates with scholars based in United States, Japan and Germany. Dorothea Scandella's co-authors include Evgueni L. Saenko, Midori Shima, Leon W. Hoyer, Hiroaki Nakai, Pete Lollar, John F. Healey, Philip J. Fay, Werner Arber, Morio Arai and CA Fulcher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Dorothea Scandella

59 papers receiving 3.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dorothea Scandella 2.8k 921 626 618 256 60 3.2k
William S. Kloetzer 440 0.2× 313 0.3× 96 0.2× 337 0.5× 127 0.5× 20 982
Sau‐Ping Kwan 222 0.1× 336 0.4× 171 0.3× 496 0.8× 369 1.4× 31 1.5k
J. G. J. Bauman 345 0.1× 111 0.1× 69 0.1× 773 1.3× 304 1.2× 37 1.4k
S Shane 409 0.1× 251 0.3× 239 0.4× 342 0.6× 100 0.4× 15 1.2k
Pamela Hamlyn 131 0.0× 215 0.2× 393 0.6× 931 1.5× 193 0.8× 20 1.5k
Kimmo K. Karhi 494 0.2× 191 0.2× 70 0.1× 342 0.6× 58 0.2× 21 944
L Nannizzi 615 0.2× 56 0.1× 218 0.3× 614 1.0× 430 1.7× 12 1.6k
Harvey A. Greisman 186 0.1× 271 0.3× 125 0.2× 859 1.4× 385 1.5× 22 1.8k
L M Pilarski 269 0.1× 87 0.1× 295 0.5× 513 0.8× 108 0.4× 50 1.5k
Gérard Lefranc 198 0.1× 138 0.1× 536 0.9× 574 0.9× 109 0.4× 27 1.1k

Countries citing papers authored by Dorothea Scandella

Since Specialization
Citations

This map shows the geographic impact of Dorothea Scandella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothea Scandella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothea Scandella more than expected).

Fields of papers citing papers by Dorothea Scandella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothea Scandella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothea Scandella. The network helps show where Dorothea Scandella may publish in the future.

Co-authorship network of co-authors of Dorothea Scandella

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothea Scandella. A scholar is included among the top collaborators of Dorothea Scandella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothea Scandella. Dorothea Scandella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scandella, Dorothea. (2002). New Characteristics of Anti-Factor VIII Inhibitor Antibody Epitopes and Unusual Immune Responses to Factor VIII. Seminars in Thrombosis and Hemostasis. 28(3). 291–296. 14 indexed citations
2.
Klinge, J., G. Auerswald, Ulrich Budde, et al.. (2001). Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay. Haemophilia. 7(1). 26–32. 11 indexed citations
3.
Scandella, Dorothea, Hiroaki Nakai, Matthew Felch, et al.. (2001). In Hemophilia A and Autoantibody Inhibitor Patients: The Factor VIII A2 Domain and Light Chain Are Most Immunogenic. Thrombosis Research. 101(5). 377–385. 32 indexed citations
4.
5.
Scandella, Dorothea. (1999). Epitope Specificity and Inactivation Mechanisms of Factor VIII Inhibitor Antibodies. Vox Sanguinis. 77(S1). 17–20. 1 indexed citations
6.
Fay, Philip J. & Dorothea Scandella. (1999). Human Inhibitor Antibodies Specific for the Factor VIII A2 Domain Disrupt the Interaction between the Subunit and Factor IXa. Journal of Biological Chemistry. 274(42). 29826–29830. 65 indexed citations
7.
Nogami, Keiji, Midori Shima, Kazuya Hosokawa, et al.. (1999). Role of Factor VIII C2 Domain in Factor VIII Binding to Factor Xa. Journal of Biological Chemistry. 274(43). 31000–31007. 72 indexed citations
8.
Nogami, Keiji, Midori Shima, Hiroaki Nakai, et al.. (1999). Identification of a factor VIII peptide, residues 2315–2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect. British Journal of Haematology. 107(1). 196–203. 24 indexed citations
9.
Scandella, Dorothea. (1999). Epitope Specificity and Inactivation Mechanisms of Factor VIII Inhibitor Antibodies. Vox Sanguinis. 77(Suppl. 1). 17–20. 21 indexed citations
10.
Kessler, Craig M., Dana Varon, U. Martinowitz, et al.. (1998). The natural history of the immune response to exogenous factor VIII in severe haemophilia A. Haemophilia. 4(4). 546–551. 16 indexed citations
11.
Saenko, Evgueni L., et al.. (1998). Activation of Factor VIII by Thrombin Increases Its Affinity for Binding to Synthetic Phospholipid Membranes and Activated Platelets. Journal of Biological Chemistry. 273(43). 27918–27926. 66 indexed citations
12.
Paleyanda, Rekha K., William H. Velander, Timothy K. Lee, et al.. (1997). Transgenic pigs produce functional human factor VIII in milk. Nature Biotechnology. 15(10). 971–975. 94 indexed citations
13.
Saenko, Evgueni L. & Dorothea Scandella. (1997). The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor. Journal of Biological Chemistry. 272(29). 18007–18014. 156 indexed citations
14.
Lubin, Ira M., John F. Healey, Rachel T. Barrow, Dorothea Scandella, & Pete Lollar. (1997). Analysis of the Human Factor VIII A2 Inhibitor Epitope by Alanine Scanning Mutagenesis. Journal of Biological Chemistry. 272(48). 30191–30195. 40 indexed citations
15.
Shima, Midori, Hiroaki Nakai, Dorothea Scandella, et al.. (1995). Common inhibitory effects of human anti‐C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor. British Journal of Haematology. 91(3). 714–721. 58 indexed citations
16.
Scandella, Dorothea, Craig M. Kessler, Deborah Hurst, et al.. (1995). Epitope specificity and functional characterization of factor VIII inhibitors. Advances in experimental medicine and biology. 386. 47–63. 20 indexed citations
17.
Saenko, Evgueni L. & Dorothea Scandella. (1995). A Mechanism for Inhibition of Factor VIII Binding to Phospholipid by von Willebrand Factor. Journal of Biological Chemistry. 270(23). 13826–13833. 81 indexed citations
18.
Healey, John F., Ira M. Lubin, Hiroaki Nakai, et al.. (1995). Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIII. Journal of Biological Chemistry. 270(24). 14505–14509. 112 indexed citations
19.
Lollar, Pete, Ernest T. Parker, Joseph E. Curtis, et al.. (1994). Inhibition of human factor VIIIa by anti-A2 subunit antibodies.. Journal of Clinical Investigation. 93(6). 2497–2504. 72 indexed citations
20.
Arai, Morio, Dorothea Scandella, & Leon W. Hoyer. (1989). Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.. Journal of Clinical Investigation. 83(6). 1978–1984. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William S. Kloetzer Breakdown of academic impact, for papers by Sau‐Ping Kwan Breakdown of academic impact, for papers by J. G. J. Bauman Breakdown of academic impact, for papers by S Shane Breakdown of academic impact, for papers by Pamela Hamlyn Breakdown of academic impact, for papers by Kimmo K. Karhi Breakdown of academic impact, for papers by L Nannizzi Breakdown of academic impact, for papers by Harvey A. Greisman Breakdown of academic impact, for papers by L M Pilarski Breakdown of academic impact, for papers by Gérard Lefranc
Rankless by CCL
2026